Basking Biosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
- First Posted Date
- 2024-01-26
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Basking Biosciences, Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT06226805
- Locations
- 🇺🇸
Valley Baptist Medical Center - Harlingen, Harlingen, Texas, United States
🇦🇺John Hunter Hospital, New Lambton Heights, New South Wales, Australia
🇦🇺Royal Adelaide Hospital, Adelaide, South Australia, Australia
Study of DTRI-031 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy VolunteersPharmacokineticsPharmacodynamics
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-08-13
- Last Posted Date
- 2022-07-19
- Lead Sponsor
- Basking Biosciences, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT05005520
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Victoria, Australia
News
No news found